Market Cap: $60.23M
HI
Heron Therapeutics, Inc.
HRTX
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $60.23M
Heron Therapeutics shows resilience in the face of challenges as it projects a robust sales outlook despite recent hurdles. The company reported net revenues of $34.7 million for Q1 2026, slightly und…
Heron Therapeutics Focuses on Pain Management Heron Therapeutics, a prominent player in the field of pain management, releases its Q4 earnings on February 26, 2026, showcasing robust growth in revenue…
### Heron Therapeutics Reports Q4 Earnings Amid Optimism for Future Growth Heron Therapeutics showcases robust financial performance in its Q4 earnings report, released on February 26, 2026. The compa…
Heron Therapeutics’ Q4 Earnings Reveal Strong Sales and Strategic Growth Heron Therapeutics (NASDAQ:HRTX) announces its Q4 earnings, reporting $35 million in revenue, marking a significant year-over-y…
Heron Data Revolutionizes SMB Credit Brokerage with New AI Automation Suite Heron Data, a pioneering AI platform focused on streamlining document-heavy workflows, is making significant strides in the…
Heron Therapeutics Launches AI-Driven Broker Suite to Revolutionize SMB Financing Heron Data, a pioneering AI platform in automating document-heavy workflows, is making strides in the small and medium…
Heron Data Launches Innovative Broker Suite to Transform SMB Credit Brokerage Heron Data, an artificial intelligence platform specializing in automating document-heavy workflows, has made a significan…
Heron Therapeutics Expands Offerings with New Infrastructure Investment Strategy Heron Therapeutics announces the launch of a private infrastructure investing strategy, designed to provide accredited…
Heron Therapeutics Expands Investment Portfolio with New Private Infrastructure Strategy Heron Therapeutics announces the launch of a private infrastructure investing strategy aimed at accredited indi…
Heron Therapeutics Launches Innovative Private Infrastructure Investment Strategy Heron Therapeutics announces the launch of a new private infrastructure investing strategy, marking a significant deve…
Heron View Partners Launches as Standalone Investment Firm Focused on Middle Market Private Equity Heron View Partners (HVP) officially announces its emergence as a standalone investment firm dedicate…
Heron View Partners Launches as Independent Private Equity Firm Heron View Partners (HVP) has officially launched as a standalone investment firm, marking a significant shift in the private equity lan…
Heron Finance: Redefining Private Credit Investment Strategies Heron Finance is making significant strides in the private credit investment landscape, particularly since the launch of its diversified…
Heron Therapeutics: Leading the Charge in Private Credit Investment Strategies Heron Finance, a division of Heron Therapeutics, showcases remarkable achievements in private credit investing, particula…
Strategic Partnership to Enhance Literacy for English Learners in China MetaMetrics® and Blue Heron Global have forged a strategic partnership aimed at improving English literacy among learners in Chi…
MetaMetrics and Blue Heron Global Forge Alliance to Transform English Literacy in China In a notable development for the education sector, MetaMetrics® has partnered with Blue Heron Global to enhance…
Heron Therapeutics Expands Investment Horizons with New Private Equity Strategy Heron Therapeutics boldly ventures into the realm of private equity with the recent launch of a new investment strategy…
Heron Therapeutics Expands Investment Horizons with New Private Equity Strategy Heron Therapeutics announces the launch of a new private equity strategy aimed at providing accredited investors and fam…
Heron Therapeutics Solidifies Investor Trust Through Strategic Custodial Partnership Heron Therapeutics takes a significant step towards enhancing investor protection with its new partnership with Ins…
Heron Therapeutics Partners with Inspira Financial to Enhance Investor Protection Heron Therapeutics embarks on a significant collaboration with Inspira Financial, aiming to fortify the safeguarding o…
Heron Therapeutics: Pioneering Innovations in Pain Management Heron Therapeutics, a biopharmaceutical company focused on developing and commercializing innovative treatments for pain management, conti…
Heron Therapeutics: Advancements in Pain Management Solutions Heron Therapeutics, a leader in innovative pain management solutions, continues to make significant strides in developing treatments that…
Transforming Management Evaluation: Blue Heron Research Partners Launches Diligence Library Blue Heron Research Partners introduces its Diligence Library, a groundbreaking resource designed to revolut…
Heron Therapeutics Partners with TFS to Revolutionize Document Processing in Finance In a significant development on October 20, 2025, Heron Data forges a strategic partnership with TFS, a prominent p…
Heron Therapeutics Partners with TFS to Revolutionize Broker Desk Operations Heron Data announces a significant collaboration with TFS, a prominent provider of equipment finance and leasing solutions,…